Related Experiment Videos
What is the minimally effective treatment for Chlamydia trachomatis infection?: The compliance paradox
Sexually Transmitted Diseases
|May 20, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Extracellular ATP hydrolysis in Caco-2 human intestinal cell line.
Biochimica et biophysica acta. Biomembranes·2021
Mpox and sexually transmitted infections: syndemic drivers of transmission and disease outcomes-A Narrative Review.
Sexually transmitted diseases·2026
Etiology of Symptomatic Male Urethritis in the Brazilian Amazon and Agreement Between Two Molecular Testing Workflows.
Sexually transmitted diseases·2026
Integrating Chlamydia and Gonorrhea Testing into a Community-Based Cohort of Latine Young Adults: Patterns and Predictors of Uptake.
Sexually transmitted diseases·2026